Early Vascular Ageing and Cellular Senescence in Chronic Kidney Disease
Open accessThe DOI matches its Crossref record; 46 of the 46 references it cites were found in a registry or an index.
Abstract
Chronic kidney disease (CKD) is a clinical model of premature ageing characterized by progressive vascular disease, systemic inflammation, muscle wasting and frailty. The predominant early vascular ageing (EVA) process mediated by medial vascular calcification (VC) results in a marked discrepancy between chronological and biological vascular age in CKD. Though the exact underlying mechanisms of VC and EVA are not fully elucidated, accumulating evidence indicates that cellular senescence - and subsequent chronic inflammation through the senescence-associated secretary phenotype (SASP) - plays a fundamental role in its initiation and progression. In this review, we discuss the pathophysiological links between senescence and the EVA process in CKD, with focus on cellular senescence and media VC, and potential anti-ageing therapeutic strategies of senolytic drugs targeting cellular senescence and EVA in CKD.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Cellular senescence: when bad things happen to good cells
Campisi, J., & d'Adda di Fagagna, F. (2007) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm2233 · Cited by 4,441
Inflammageing: chronic inflammation in ageing, cardiovascular disease, and frailty
Ferrucci, L., & Fabbri, E. (2018) · Nature Reviews Cardiology · doi:10.1038/s41569-018-0064-2 · Cited by 3,690 · cited 1×
“Of note, concomitant with cellular senescence, another common feature of ageing-related conditions is persistent low-grade sterile inflammation, “inflammaging” [36,37].”
BackgroundA new regulatory motif in cell-cycle control causing specific inhibition of cyclin D/CDK4.
Serrano, M., Hannon, G. J., & Beach, D. (1993) · Nature · doi:10.1038/366704a0 · Cited by 3,650
The role of senescent cells in ageing
van Deursen, J. M. (2014) · Nature · doi:10.1038/nature13193 · Cited by 2,623
The Achilles' heel of senescent cells: from transcriptome to senolytic drugs
Zhu, Y., Tchkonia, T., Pirtskhalava, T., Gower, A. C., Ding, H., Giorgadze, N., Palmer, A. K., Ikeno, Y., Hubbard, G. B., Lenburg, M., et al. (2015) · Aging Cell · doi:10.1111/acel.12344 · Cited by 2,584 · cited 12×
“Both agents were shown to induce apoptosis in senescent cells with dasatinib targeting the dependence receptors/tyrosine kinase SCAP and quercetin targeting the BCL2/BCL-XL, PI3K/AKT, and p53/ p21/serpine SCAPs [22,62,63].”
BackgroundInfluentialCellular senescence in aging and age-related disease: from mechanisms to therapy
Childs, B. G., Durik, M., Baker, D. J., & van Deursen, J. M. (2015) · Nature Medicine · doi:10.1038/nm.4000 · Cited by 2,363 · cited 1×
“Potential markers include an increase in cell size; high expression of p16 and p21; elevated cellular senescence-associated β-galactosidase (SA-β-Gal) enzymatic activity; positive telomere-associated DNAdamage foci and expression of SASP factors [70].”
BackgroundSenolytics improve physical function and increase lifespan in old age
Xu, M., Pirtskhalava, T., Farr, J. N., Weigand, B. M., Palmer, A. K., Weivoda, M. M., Inman, C. L., Ogrodnik, M. B., Hachfeld, C. M., Fraser, D. G., et al. (2018) · Nature Medicine · doi:10.1038/s41591-018-0092-9 · Cited by 2,287
Rb-mediated heterochromatin formation and silencing of E2F target genes during cellular senescence
Narita, M., Nuñez, S., Heard, E., Narita, M., Lin, A. W., Hearn, S. A., Spector, D. L., Hannon, G. J., & Lowe, S. W. (2003) · Cell · doi:10.1016/s0092-8674(03)00401-x · Cited by 2,278 · cited 1×
“heterochromatic repression of genes encoding cyclins, many of which are activation targets of E2F transcription factors [46].”
BackgroundPersistent DNA damage signalling triggers senescence-associated inflammatory cytokine secretion
Rodier, F., Coppé, J.-P., Patil, C. K., Hoeijmakers, W. A. M., Muñoz, D. P., Raza, S. R., Freund, A., Campeau, E., Davalos, A. R., & Campisi, J. (2009) · Nature Cell Biology · doi:10.1038/ncb1909 · Cited by 2,232
Franceschi, C., Capri, M., Monti, D., Giunta, S., Olivieri, F., Sevini, F., Panourgia, M. P., Invidia, L., Celani, L., Scurti, M., et al. (2007) · Mechanisms of Ageing and Development · doi:10.1016/j.mad.2006.11.016 · Cited by 2,087
Four faces of cellular senescence
Rodier, F., & Campisi, J. (2011) · Journal of Cell Biology · doi:10.1083/jcb.201009094 · Cited by 2,070
An Essential Role for Senescent Cells in Optimal Wound Healing through Secretion of PDGF-AA
Demaria, M., Ohtani, N., Youssef, S. A., Rodier, F., Toussaint, W., Mitchell, J. R., Laberge, R.-M., Vijg, J., Van Steeg, H., Dollé, M. E. T., et al. (2014) · Developmental Cell · doi:10.1016/j.devcel.2014.11.012 · Cited by 2,045
Suppression of Aging in Mice by the Hormone Klotho
Kurosu, H., Yamamoto, M., Clark, J. D., Pastor, J. V., Nandi, A., Gurnani, P., McGuinness, O. P., Chikuda, H., Yamaguchi, M., Kawaguchi, H., et al. (2005) · Science · doi:10.1126/science.1112766 · Cited by 1,935
Cellular senescence and the senescent secretory phenotype: therapeutic opportunities
Tchkonia, T., Zhu, Y., van Deursen, J., Campisi, J., & Kirkland, J. L. (2013) · Journal of Clinical Investigation · doi:10.1172/jci64098 · Cited by 1,774 · cited 4×
“mains to be determined, but one possible origin could be derived from senescent cells that develop a senescence-associated secretory phenotype (SASP), characterized by a secretion profile with excretion of pro-inflammatory cytokines, growth factors and soluble receptors that poison the surrounding tissues and affect t…”
BackgroundInfluentialThe RB and p53 pathways in cancer
Sherr, C. J., & McCormick, F. (2002) · Cancer Cell · doi:10.1016/s1535-6108(02)00102-2 · Cited by 1,690 · cited 1×
“that of activation by p16, at least in some respects [45].”
BackgroundThe ATM protein kinase: regulating the cellular response to genotoxic stress, and more
Shiloh, Y., & Ziv, Y. (2013) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm3546 · Cited by 1,649 · cited 5×
“Another fact supporting the involvement of senescence in media VC is that the activation of ATM and ataxia telangiectasia and Rad3-related (ATR) kinases in DDR signaling acts as a key factor in osteogenic differentiation and calcification of VSMCs; inhibition of this pathway prevents osteogenesis of VSMCs in vitro [10…”
BackgroundInfluentialCellular senescence mediates fibrotic pulmonary disease
Schafer, M. J., White, T. A., Iijima, K., Haak, A. J., Ligresti, G., Atkinson, E. J., Oberg, A. L., Birch, J., Salmonowicz, H., Zhu, Y., et al. (2017) · Nature Communications · doi:10.1038/ncomms14532 · Cited by 1,613 · cited 1×
“For instance, navitoclax, targeting the B-cell lymphoma (Bcl-2) family of proteins, is effective as a senolytic in human umbilical vein endothelial and lung fibroblastlike cell strains but not in primary human fat cell progenitors nor primary human lung fibroblasts [24,68].”
BackgroundReversal of human cellular senescence: roles of the p53 and p16 pathways
Beauséjour, C. M., Krtolica, A., Galimi, F., Narita, M., Lowe, S. W., Yaswen, P., & Campisi, J. (2003) · The EMBO Journal · doi:10.1093/emboj/cdg417 · Cited by 1,457
Senolytics in idiopathic pulmonary fibrosis: Results from a first-in-human, open-label, pilot study
Justice, J. N., Nambiar, A. M., Tchkonia, T., LeBrasseur, N. K., Pascual, R., Hashmi, S. K., Prata, L., Masternak, M. M., Kritchevsky, S. B., Musi, N., et al. (2019) · EBioMedicine · doi:10.1016/j.ebiom.2018.12.052 · Cited by 1,261
Oncogene-induced senescence as an initial barrier in lymphoma development
Braig, M., Lee, S., Loddenkemper, C., Rudolph, C., Peters, A. H. F. M., Schlegelberger, B., Stein, H., Dörken, B., Jenuwein, T., & Schmitt, C. A. (2005) · Nature · doi:10.1038/nature03841 · Cited by 1,220
Molecular inflammation: Underpinnings of aging and age-related diseases
Chung, H. Y., Cesari, M., Anton, S., Marzetti, E., Giovannini, S., Seo, A. Y., Carter, C., Yu, B. P., & Leeuwenburgh, C. (2009) · Ageing Research Reviews · doi:10.1016/j.arr.2008.07.002 · Cited by 1,203
Zhu, Y., Tchkonia, T., Fuhrmann‐Stroissnigg, H., Dai, H. M., Ling, Y. Y., Stout, M. B., Pirtskhalava, T., Giorgadze, N., Johnson, K. O., Giles, C. B., et al. (2016) · Aging Cell · doi:10.1111/acel.12445 · Cited by 1,148 · cited 1×
“For instance, navitoclax, targeting the B-cell lymphoma (Bcl-2) family of proteins, is effective as a senolytic in human umbilical vein endothelial and lung fibroblastlike cell strains but not in primary human fat cell progenitors nor primary human lung fibroblasts [24,68].”
BackgroundChien, Y., Scuoppo, C., Wang, X., Fang, X., Balgley, B., Bolden, J. E., Premsrirut, P., Luo, W., Chicas, A., Lee, C. S., et al. (2011) · Genes & Development · doi:10.1101/gad.17276711 · Cited by 1,046
Cellular senescence: a translational perspective
Kirkland, J. L., & Tchkonia, T. (2017) · EBioMedicine · doi:10.1016/j.ebiom.2017.04.013 · Cited by 1,013
Jun, J.-I., & Lau, L. F. (2010) · Nature Cell Biology · doi:10.1038/ncb2070 · Cited by 998
Xu, M., Tchkonia, T., Ding, H., Ogrodnik, M., Lubbers, E. R., Pirtskhalava, T., White, T. A., Johnson, K. O., Stout, M. B., Mezera, V., et al. (2015) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1515386112 · Cited by 915
Hewitt, G., Jurk, D., Marques, F. D. M., Correia-Melo, C., Hardy, T., Gackowska, A., Anderson, R., Taschuk, M., Mann, J., & Passos, J. F. (2012) · Nature Communications · doi:10.1038/ncomms1708 · Cited by 908
Roos, C. M., Zhang, B., Palmer, A. K., Ogrodnik, M. B., Pirtskhalava, T., Thalji, N. M., Hagler, M., Jurk, D., Smith, L. A., Casaclang‐Verzosa, G., et al. (2016) · Aging Cell · doi:10.1111/acel.12458 · Cited by 738
Identification of HSP90 inhibitors as a novel class of senolytics
Fuhrmann-Stroissnigg, H., Ling, Y. Y., Zhao, J., McGowan, S. J., Zhu, Y., Brooks, R. W., Grassi, D., Gregg, S. Q., Stripay, J. L., Dorronsoro, A., et al. (2017) · Nature Communications · doi:10.1038/s41467-017-00314-z · Cited by 701
Tumor suppression by Ink4a-Arf: progress and puzzles.
Lowe, S. W., & Sherr, C. J. (2003) · Current Opinion in Genetics & Development · doi:10.1016/s0959-437x(02)00013-8 · Cited by 699 · cited 1×
“Thus, the activation p16/pRB pathway is essentially irreversible and it is primarily triggered by oncogene mutations and various stress [47].”
BackgroundHuman longevity at the cost of reproductive success
Westendorp, R. G. J., & Kirkwood, T. B. L. (1998) · Nature · doi:10.1038/25519 · Cited by 607
Loss of p16Ink4a confers susceptibility to metastatic melanoma in mice
Krimpenfort, P., Quon, K. C., Mooi, W. J., Loonstra, A., & Berns, A. (2001) · Nature · doi:10.1038/35092584 · Cited by 568 · cited 1×
“On the one hand, the inhibition of p16, pRB, p53 or p21 tumor suppressor pathways could diminish the defensive effect of senescent cells against cancer and increase the risk of cancer development [116].”
BackgroundThe Clinical potential of Senolytic Drugs
Kirkland, J. L., Tchkonia, T., Zhu, Y., Niedernhofer, L. J., & Robbins, P. D. (2017) · Journal of the American Geriatrics Society · doi:10.1111/jgs.14969 · Cited by 539 · cited 2×
“SA-β-Gal activity, p16, p21, and telomere-associated foci) [61,66].”
BackgroundBRD4 Connects Enhancer Remodeling to Senescence Immune Surveillance
Tasdemir, N., Banito, A., Roe, J.-S., Alonso-Curbelo, D., Camiolo, M., Tschaharganeh, D. F., Huang, C.-H., Aksoy, O., Bolden, J. E., Chen, C.-C., et al. (2016) · Cancer Discovery · doi:10.1158/2159-8290.cd-16-0217 · Cited by 415 · cited 1×
“However, while SASP inhibitors would reduce the systemic burden of senescent cell-associated inflammation without interfering with antioncogenic pathways, this intervention may also act through other drug-specific mechanisms that potentially could impair immune cell clearance capacity, resulting in a risk of excessive…”
BackgroundWhen cells get stressed: an integrative view of cellular senescence
Ben-Porath, I., & Weinberg, R. A. (2004) · Journal of Clinical Investigation · doi:10.1172/jci200420663 · Cited by 404
The evolution of diverse biological responses to DNA damage: insights from yeast and p53
Wahl, G. M., & Carr, A. M. (2001) · Nature Cell Biology · doi:10.1038/ncb1201-e277 · Cited by 376
Cellular senescence: putting the paradoxes in perspective
Campisi, J. (2011) · Current Opinion in Genetics & Development · doi:10.1016/j.gde.2010.10.005 · Cited by 368
Cellular senescence in renal ageing and disease
Sturmlechner, I., Durik, M., Sieben, C. J., Baker, D. J., & van Deursen, J. M. (2017) · Nature Reviews Nephrology · doi:10.1038/nrneph.2016.183 · Cited by 345 · cited 3×
“mains to be determined, but one possible origin could be derived from senescent cells that develop a senescence-associated secretory phenotype (SASP), characterized by a secretion profile with excretion of pro-inflammatory cytokines, growth factors and soluble receptors that poison the surrounding tissues and affect t…”
BackgroundCellular senescence and the senescent secretory phenotype in age-related chronic diseases
Zhu, Y., Armstrong, J. L., Tchkonia, T., & Kirkland, J. L. (2014) · Current Opinion in Clinical Nutrition and Metabolic Care · doi:10.1097/mco.0000000000000065 · Cited by 273
Hubackova, S., Krejcikova, K., Bartek, J., & Hodny, Z. (2012) · Aging · doi:10.18632/aging.100520 · Cited by 272 · cited 1×
“to mediate senescence and accounts for components of a positive feedback loop that regulates the SASP [59].”
BackgroundCellular senescence controls fibrosis in wound healing
Jun, J.-I., & Lau, L. F. (2010) · Aging · doi:10.18632/aging.100201 · Cited by 255
VHL loss actuates a HIF-independent senescence programme mediated by Rb and p400
Young, A. P., Schlisio, S., Minamishima, Y. A., Zhang, Q., Li, L., Grisanzio, C., Signoretti, S., & Kaelin, W. G. (2008) · Nature Cell Biology · doi:10.1038/ncb1699 · Cited by 239
Cellular senescence in the aging and diseased kidney
Valentijn, F. A., Falke, L. L., Nguyen, T. Q., & Goldschmeding, R. (2018) · Journal of Cell Communication and Signaling · doi:10.1007/s12079-017-0434-2 · Cited by 173
Melk, A., Schmidt, B. M. W., Vongwiwatana, A., Rayner, D. C., & Halloran, P. F. (2005) · American Journal of Transplantation · doi:10.1111/j.1600-6143.2005.00846.x · Cited by 154
Adult-onset, short-term dietary restriction reduces cell senescence in mice
Wang, C., Maddick, M., Miwa, S., Jurk, D., Czapiewski, R., Saretzki, G., Langie, S. A. S., Godschalk, R. W. L., Cameron, K., & von Zglinicki, T. (2010) · Aging · doi:10.18632/aging.100196 · Cited by 142 · cited 1×
“For instance, caloric restriction, which delays cellular senescence, and slows down VC and ageing, was shown to be an effective approach to extend the lifespan in animals [114,117].”
BackgroundCell-adhesion-disrupting action of interleukin 6 in human ductal breast carcinoma cells.
Tamm, I., Kikuchi, T., Cardinale, I., & Krueger, J. G. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.8.3329 · Cited by 47 · cited 1×
“nescence growth arrest at least in some senescent cells as a cancerprotective defence [54]; on the other hand, malignant cancers exploit the SASP factors to stimulate growth, angiogenesis, and epithelial-tomesenchymal transition (EMT) that further promote metastases and cancer progression [55,56].”
Background
Research works printed but not linked: 77
- Kooman J.P., Broers N.J.H., Usvyat L., Thijssen S., Van Der Sande F.M., Cornelis T. et al: Out of control: accelerated aging in uremia. Nephrol Dial Transplant 2013; 28: 48. · DOI
- Kooman J.P., Shiels P.G. and Stenvinkel P.: Premature aging in chronic kidney disease and chronic obstructive pulmonary disease: similarities and differences. Curr Opin Clin Nutr Metab Care 2015; 18: 528.
- Girndt M. and Seibert E.: Premature cardiovascular disease in chronic renal failure (CRF): a model for an advanced ageing process. Exp Gerontol 2010; 45: 797. · DOI
- 10.1038/nrneph.2014.185 · DOI · Paper page
- 10.1053/j.ajkd.2012.11.051 · DOI · Paper page
- Cunha P.G., Boutouyrie P., Nilsson P.M. and Laurent S.: Early vascular ageing (EVA): definitions and clinical applicability. Curr Hypertens Rev 2017; 13: 1. · DOI
- Shanahan C.M.: Mechanisms of vascular calcification in CKD - evidence for premature ageing?. Nat Rev Nephrol 2013; 9: 661. · DOI · Paper page
- Shroff R., Long D.A. and Shanahan C.: Mechanistic insights into vascular calcification in CKD. J Am Soc Nephrol 2013; 24: 179. · DOI · Paper page
- McGlynn L.M., Stevenson K., Lamb K., Zino S., Brown M., Prina A. et al: Cellular senescence in pretransplant renal biopsies predicts postoperative organ function. Aging Cell 2009; 8: 45. · DOI
- 10.1074/jbc.M409153200 · DOI · Paper page
- 10.1016/0014-4827(61)90192-6 · DOI · Paper page
- Hayflick L.: The limited in vitro lifetime of human diploid cell strains. Exp Cell Res 1965; 37: 614. · DOI · Paper page
- Xia L., Huang Q., Chen X., Yin Z., Zhang Y., Lun L. et al: Youthful systemic milieu alleviates renal ischemia-reperfusion injury in elderly mice. Kidney Int 2018; 94: 268. · DOI
- Plotkin M.: Young blood for old kidneys? More questions than answers so far. Kidney Int 2018; 94: 235. · DOI
- Keung L. and Perwad F.: Vitamin D and kidney disease. Bone Rep 2018; 9: 93. · DOI
- Kim S.-H., Rowe J., Fujii H., Jones R., Schmierer B., Kong B.-W. et al: Upregulation of chicken p15INK4b at senescence and in the developing brain. J Cell Sci 2006; 119: 2435. · DOI · Paper page
- 10.1016/j.cell.2013.10.041 · DOI · Paper page
- 10.1097/HJH.0b013e3283399326 · DOI
- Childs B.G., Baker D.J., Wijshake T., Conover C.A., Campisi J. and van Deursen J.M.: Senescent intimal foam cells are deleterious at all stages of atherosclerosis. Science (New York, NY) 2016; 354: 472. · DOI · Paper page
- Kooman J.P., Dekker M.J., Usvyat L.A., Kotanko P., van der Sande F.M., Schalkwijk C.G. et al: Inflammation and premature aging in advanced chronic kidney disease. Am J Physiol Renal Physiol 2017; 313: F938. · DOI · Paper page
- 10.1046/j.1474-9728.2003.00048.x · DOI · Paper page
- 10.1038/nbt0702-682 · DOI · Paper page
- Brown J.P., Wei W. and Sedivy J.M.: Bypass of senescence after disruption of p21CIP1/WAF1 gene in normal diploid human fibroblasts. Science (New York, NY) 1997; 277: 831. · DOI · Paper page
- Kipling D., Davis T., Ostler E.L. and Faragher R.G.A.: What can progeroid syndromes tell us about human aging?. Science (New York, NY) 2004; 305: 1426. · DOI · Paper page
- 10.1038/nm.2014 · DOI · Paper page
- 10.1016/j.ccr.2004.09.028 · DOI · Paper page
- 10.1046/j.1365-2443.2003.00620.x · DOI · Paper page
- 10.1016/j.kint.2018.12.014 · DOI
- Anand David A., Arulmoli R. and Parasuraman S.: Overviews of biological importance of quercetin: a bioactive flavonoid. Pharmacognosy Reviews 2016; 10: 84. · DOI · Paper page
- 10.1021/jm049486a · DOI · Paper page
- Xu M., Bradley E.W., Weivoda M.M., Hwang S.M., Pirtskhalava T., Decklever T. et al: Transplanted senescent cells induce an osteoarthritis-like condition in mice. J Gerontol A Biol Sci Med Sci 2017; 72: 780.
- Gradin P., Hollberg K., Cassady A.I., Lång P., Andersson G., Lang P. et al: Transgenic overexpression of tartrate-resistant acid phosphatase is associated with induction of osteoblast gene expression and increased cortical bone mineral content and density. Cells Tissues Organs 2012; 196: 68. · DOI
- Mikhailova M.V., Belyaeva N.F., Kozlova N.I., Zolotarev K.V., Mikhailov A.N., Berman A.E. et al: Protective action of fish muscle extracts against cellular senescence induced by oxidative stress. Biomeditsinskaya Khim 2017; 63: 351. · DOI
- Kovacovicova K., Skolnaja M., Heinmaa M., Mistrik M., Pata P., Pata I. et al: Senolytic cocktail Dasatinib+quercetin (D+Q) does not enhance the efficacy of senescence-inducing chemotherapy in liver cancer. Front Oncol 2018; 8: 459. · DOI · Paper page
- Stenvinkel P., Meyer C.J., Block G.A., Chertow G. and Shiels P.G.: Understanding the role of the cytoprotective transcription factor NRF2 - Lessons from evolution, the animal kingdom and rare progeroid syndromes. Nephrol Dial Transpl 2019; . [In Press].
- Covic A., Vervloet M., Massy Z.A., Torres P.U., Goldsmith D., Brandenburg V. et al: Bone and mineral disorders in chronic kidney disease: implications for cardiovascular health and ageing in the general population. Lancet Diabetes Endocrinol 2018; 6: 319. · DOI · Paper page
- 10.1016/j.mad.2006.11.015 · DOI · Paper page
- Carrero J.J., Stenvinkel P., Fellström B., Qureshi A.R., Lamb K., Heimbürger O. et al: Telomere attrition is associated with inflammation, low fetuin-a levels and high mortality in prevalent haemodialysis patients. J Intern Med 2008; 263: 302. · DOI · Paper page
- Carrero J.J. and Stenvinkel P.: Persistent inflammation as a catalyst for other risk factors in chronic kidney disease: a hypothesis proposal. Clin J Am Soc Nephrol 2009; 4: S49. · DOI · Paper page
- Yamada S., Tatsumoto N., Tokumoto M., Noguchi H., Ooboshi H., Kitazono T. et al: Phosphate binders prevent phosphate-induced cellular senescence of vascular smooth muscle cells and vascular calcification in a modified, adenine-based uremic rat model. Calcif Tissue Int 2015; 96: 347. · DOI
- 10.1371/journal.pone.0092115 · DOI
- 10.1152/ajprenal.00527.2012 · DOI
- 10.18632/aging.101173 · DOI
- 10.1053/j.ajkd.2010.12.027 · DOI · Paper page
- Drüeke T.B. and Massy Z.A.: Circulating klotho levels: clinical relevance and relationship with tissue klotho expression. Kidney Int 2013; 83: 13. · DOI
- Maltese G., Psefteli P.-M., Rizzo B., Srivastava S., Gnudi L., Mann G.E. et al: The anti-ageing hormone klotho induces Nrf2-mediated antioxidant defences in human aortic smooth muscle cells. J Cell Mol Med 2017; 21: 621. · DOI
- 10.1161/HYPERTENSIONAHA.116.07709 · DOI
- Makulska I., Szczepańska M., Drożdż D., Polak-Jonkisz D. and Zwolińska D.: The importance of fetuin-A in vascular calcification in children with chronic kidney disease. In: Advances in Clinical and Experimental Medicine. : Official Organ Wroclaw Medical University 2018.
- Al-Biltagi M., ElHafez M.A.A., El Amrousy D.M., El-Gamasy M. and El-Serogy H.: Evaluation of the coronary circulation and calcification in children on regular hemodialysis. Pediatr Nephrol (Berlin, Germany) 2017; 32: 1941. · DOI
- Shroff R.C., McNair R., Figg N., Skepper J.N., Schurgers L., Gupta A. et al: Dialysis accelerates medial vascular calcification in part by triggering smooth muscle cell apoptosis. Circulation 2008; 118: 1748. · DOI · Paper page
- Yamada S., Taniguchi M., Tokumoto M., Toyonaga J., Fujisaki K., Suehiro T. et al: The antioxidant tempol ameliorates arterial medial calcification in uremic rats: important role of oxidative stress in the pathogenesis of vascular calcification in chronic kidney disease. J Bone Mineral Res 2012; 27: 474. · DOI
- McCabe K.M., Booth S.L., Fu X., Shobeiri N., Pang J.J., Adams M.A. et al: Dietary vitamin K and therapeutic warfarin alter the susceptibility to vascular calcification in experimental chronic kidney disease. Kidney Int 2013; 83: 835. · DOI
- 10.1161/CIRCRESAHA.110.234914 · DOI · Paper page
- Vaziri N.D.: Oxidative stress in uremia: nature, mechanisms, and potential consequences. Semin Nephrol 2004; 24: 469. · DOI · Paper page
- Goettsch C., Weis D., Kramann R., Hellmann B., Floege J., Schurgers L. et al: Magnesium but not nicotinamide prevents vascular calcification in experimental uraemia. Nephrol Dial Transplant 2019; : 1.
- Holt S.G. and Smith E.R.: Fetuin-A-containing calciprotein particles in mineral trafficking and vascular disease. Nephrol Dial Transplant 2016; 31: 1583. · DOI
- Eleftheriadou I., Grigoropoulou P., Kokkinos A., Mourouzis I., Perrea D., Katsilambros N. et al: Association of plasma fetuin-a levels with peripheral arterial disease and lower extremity arterial calcification in subjects with type 2 diabetes mellitus. J Diabetes Complications 2017; 31: 599. · DOI
- Viegas C.S.B., Santos L., Macedo A.L., Matos A.A., Silva A.P., Neves P.L. et al: Chronic kidney disease circulating Calciprotein particles and extracellular vesicles promote vascular calcification: a role for GRP (Gla-rich protein). Arterioscler Thromb Vasc Biol 2018; 38: 575. · DOI
- 10.1016/j.yexcr.2016.06.007 · DOI · Paper page
- Lin M.-E., Chen T., Leaf E.M., Speer M.Y. and Giachelli C.M.: Runx2 expression in smooth muscle cells is required for arterial medial calcification in mice. Am J Pathol 2015; 185: 1958. · DOI
- Sun Y., Byon C.H., Yuan K., Chen J., Mao X., Heath J.M. et al: Smooth muscle cell-specific runx2 deficiency inhibits vascular calcification. Circ Res 2012; 111: 543. · DOI · Paper page
- Voelkl J., Lang F., Eckardt K.-U., Amann K., Kuro-O M., Pasch A. et al: Signaling pathways involved in vascular smooth muscle cell calcification during hyperphosphatemia. Cell Mol Life Sci 2019; 76: 2077.
- Voelkl J., Tuffaha R., Luong T.T.D.D., Zickler D., Masyout J., Feger M. et al: Zinc inhibits phosphate-induced vascular calcification through TNFAIP3-mediated suppression of NF-kappaB. J Am Soc Nephrol 2018; 29: 1636. · DOI · Paper page
- Xu Z., Ji G., Shen J., Wang X., Zhou J. and Li L.: SOX9 and myocardin counteract each other in regulating vascular smooth muscle cell differentiation. Biochem Biophys Res Commun 2012; 422: 285. · DOI
- Voelkl J., Luong T.T.D.T., Tuffaha R., Musculus K., Auer T., Lian X. et al: SGK1 induces vascular smooth muscle cell calcification through NF-κB signaling. J Clin Investig 2018; 128: 3024. · DOI · Paper page
- Giachelli C.M.: The emerging role of phosphate in vascular calcification. Kidney Int 2009; 75: 890. · DOI · Paper page
- Opdebeeck B., Maudsley S., Azmi A., De Maré A., De Leger W., Meijers B. et al: Indoxyl sulfate and p-Cresyl sulfate promote vascular calcification and associate with glucose intolerance. J Am Soc Nephrol 2019; . ASN.2018060609. · DOI · Paper page
- Iyemere V.P., Proudfoot D., Weissberg P.L. and Shanahan C.M.: Vascular smooth muscle cell phenotypic plasticity and the regulation of vascular calcification. J Intern Med 2006; 260: 192. · DOI · Paper page
- 10.1161/CIRCULATIONAHA.109.902056 · DOI · Paper page
- Liu Y., Drozdov I., Shroff R., Beltran L.E. and Shanahan C.M.: Prelamin a accelerates vascular calcification via activation of the DNA damage response and senescence-associated secretory phenotype in vascular smooth muscle cells. Circ Res 2013; 112: e99.
- Song Y., Shen H., Schenten D., Shan P., Lee P.J. and Goldstein D.R.: Aging enhances the basal production of IL-6 and CCL2 in vascular smooth muscle cells. Arterioscler Thromb Vasc Biol 2012; 32: 103. · DOI
- 10.1073/pnas.0511133103 · DOI · Paper page
- 10.1152/ajpcell.00329.2011 · DOI
- 10.1038/nrneph.2017.169 · DOI
- Jazani NH Savoj J Lustgarten M Lau WL Vaziri ND. Impact of Gut Dysbiosis on Neurohormonal Pathways in Chronic Kidney Disease. Diseases (Basel Switzerland) 2019;7. doi:https://doi.org/10.3390/diseases7010021. · DOI
- Tchkonia T. and Kirkland J.L.: Therapeutic approaches to aging-reply. JAMA 2019; 321: 901. · DOI
- Ridker P.M., MacFadyen J.G., Glynn R.J., Koenig W., Libby P., Everett B.M. et al: Inhibition of interleukin-1β by Canakinumab and cardiovascular outcomes in patients with chronic kidney disease. J Am Coll Cardiol 2018; 71: 2405. · DOI · Paper page
Cited by
Hickson, L. J., Langhi Prata, L. G. P., Bobart, S. A., Evans, T. K., Giorgadze, N., Hashmi, S. K., Herrmann, S. M., Jensen, M. D., Jia, Q., Jordan, K. L., et al. (2019) · EBioMedicine · doi:10.1016/j.ebiom.2019.08.069 · Cited by 1,383
Food as medicine: targeting the uraemic phenotype in chronic kidney disease
Mafra, D., Borges, N. A., Lindholm, B., Shiels, P. G., Evenepoel, P., & Stenvinkel, P. (2021) · Nature Reviews Nephrology · doi:10.1038/s41581-020-00345-8 · Cited by 238
Self-citationWang, Y., Wang, Y., Yang, M., & Ma, X. (2021) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2020.111191 · Cited by 34
Metadata
- Authors
- Dai, L., Qureshi, A. R., Witasp, A., Lindholm, B., & Stenvinkel, P.
- Venue
- Computational and Structural Biotechnology Journal
- Published
- 2019
- Volume
- 17
- Pages
- 721-729
- ISSN
- 2001-0370 (ISSN-L)
- OpenAlex
- W2950937096
- Cited by
- 94
- References
- 46
- FWCI
- 7.86
- Type
- journal article
- Language
- en
- Open access
- gold
- Licence
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- www.elsevier.com/legal/tdmrep-license (tdm)
- creativecommons.org/licenses/by-nc-nd/4.0/ (vor, 161 d)
- Funders
- H2020 Marie Skłodowska-Curie Actions (722609)
- Vetenskapsrådet (2009-1068)
- Karolinska Institutet
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.